公司报告本季度总产品销售额略有下降,为2870万美元,低于上一季度的3070万美元,主要是由于INDOCIN销售额下降。尽管整体销售有所下滑,但Assertio的旗舰产品ROLVEDON仍保持了1500万美元的稳定销售。公司正专注于增长机会,特别是通过扩大ROLVEDON的市场存在和利用尚未 ...

Q3 2024 Earnings Call Transcript November 11, 2024 Operator: Thank you for standing by. My name is John, and I’ll be your conference operator today. At this time, I would like to welcome everyone to ...

Thank you for standing by. My name is John, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Assertio Holdings third-quarter results conference call.

Third Quarter Total Net Product Sales of $28.7 MillionRolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 ...

The company achieved an adjusted EBITDA of $5.3 million, primarily driven by reduced selling, general, and administrative expenses. Sales of Rolvedon remained stable, while Indocin sales faced ...

Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 (GLOBE NEWSWIRE) ...